ArticleScientific reports2021

A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics.

Anthony D Verderosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.